Founded in 1980, Technology Partners was a venture capital firm headquartered in Novato, California. The firm preferred to invest in companies operating in the clean technology and life science sectors.
Benvenue Medical, Inc. specializes in the design, manufacturing, and marketing of minimally invasive expandable implant systems for treating spinal disorders, specifically vertebral compression fractures and degenerative disc diseases. The company offers products such as the Kiva system, which addresses spinal fractures in the thoracic and lumbar regions, and the Blazer – C system, aimed at treating various types of pathological vertebral compression fractures. Additionally, Benvenue Medical has introduced the Luna 3D, an expandable interbody fusion system designed for use in minimally invasive, mini-open, or open surgical procedures. Established in 2004 and headquartered in Santa Clara, California, the company serves a diverse customer base in the United States, Canada, Belgium, France, and Germany.
Elcelyx was founded in 2010 with venture capital backing based on Gut Sensory Modulation (GSM) technology. Elcelyx’s proprietary, first-in-class Gut Sensory Modulators are delivered directly to the lower gut where they act on molecular targets to elicit physiological and pharmacological effects. The Elcelyx proprietary product candidate, NewMet for Type 2 diabetes is entering Phase 2b development and is a blockbuster opportunity designed to address the unmet needs in the oral anti-diabetic market. Elcelyx is led by an experienced management team and Board of Directors with track records of success in drug development and commercialization. Premier investors along with seasoned scientists and clinicians support the team. In September 2013, Elcelyx announced the formation of NaZura BioHealth Inc, a separate company established to focus on the development on non-NewMet assets. Elcelyx is headquartered in San Diego, California.
KAIAM is a private company that specializes in the design and manufacture of photonic integrated circuits and optical components aimed at high-speed data transfer. The company develops gadgets that facilitate the transmission and reception of data at very high speeds, catering primarily to the needs of computer networking and hyper-scale data centers. KAIAM produces a range of products, including optical sub-assemblies, modules, and transceivers, utilizing advanced technologies such as micromachined silicon. One of their notable innovations is the CWDM4, a 100 Gigabit-per-second coarse wavelength division multiplexing transceiver, which highlights their commitment to delivering high-quality optical networking solutions for various applications in the fiber optics communications industry.
Benvenue Medical, Inc. specializes in the design, manufacturing, and marketing of minimally invasive expandable implant systems for treating spinal disorders, specifically vertebral compression fractures and degenerative disc diseases. The company offers products such as the Kiva system, which addresses spinal fractures in the thoracic and lumbar regions, and the Blazer – C system, aimed at treating various types of pathological vertebral compression fractures. Additionally, Benvenue Medical has introduced the Luna 3D, an expandable interbody fusion system designed for use in minimally invasive, mini-open, or open surgical procedures. Established in 2004 and headquartered in Santa Clara, California, the company serves a diverse customer base in the United States, Canada, Belgium, France, and Germany.
ForSight VISION5, founded in 2010 as part of ForSight Labs, specializes in developing innovative drug delivery technologies aimed at treating various eye conditions. The company focuses on creating non-invasive products designed to replace traditional eye drops, offering sustained therapy for significant eye diseases such as glaucoma, dry eye, and allergies. Currently, ForSight VISION5 is in its second Phase 2 clinical study for its lead product, the Helios insert, which represents a significant advancement in ocular treatment options.
ForSight Labs is dedicated to developing innovative ophthalmic technologies aimed at enhancing the sight and quality of life for visually impaired patients. The organization collaborates with entrepreneurs, investors, and clinicians to drive advancements in eye care through the creation and commercialization of high-impact solutions. With millions of individuals in the U.S. suffering from vision impairment and the associated economic burden exceeding $50 billion annually, ForSight Labs addresses a significant public health challenge. Their focus includes developing treatments for conditions such as glaucoma, which can lead to irreversible blindness in adults. By fostering a creative and cooperative environment, ForSight Labs strives to deliver effective solutions to the ophthalmic community and the patients it serves.
Transcend Medical, Inc. is an ophthalmic device company dedicated to developing medical devices for the treatment of glaucoma, a leading cause of irreversible blindness in adults. Founded in 2005 and based in Menlo Park, California, the company emerged from ForSight Labs and focuses on minimally invasive solutions to replace traditional invasive therapies. Its flagship product, the CyPass Micro-Stent, is designed to be inserted during routine cataract surgery to help reduce intraocular pressure. Transcend Medical also offers the Vold Gonio Lens for use in micro-invasive glaucoma surgery and provides clinical trial services. The CyPass Micro-Stent received CE mark approval in 2008 and has been evaluated in various clinical studies, including the COMPASS multi-center trial. The company operates as a subsidiary of Alcon Holdings, Inc.
Elcelyx was founded in 2010 with venture capital backing based on Gut Sensory Modulation (GSM) technology. Elcelyx’s proprietary, first-in-class Gut Sensory Modulators are delivered directly to the lower gut where they act on molecular targets to elicit physiological and pharmacological effects. The Elcelyx proprietary product candidate, NewMet for Type 2 diabetes is entering Phase 2b development and is a blockbuster opportunity designed to address the unmet needs in the oral anti-diabetic market. Elcelyx is led by an experienced management team and Board of Directors with track records of success in drug development and commercialization. Premier investors along with seasoned scientists and clinicians support the team. In September 2013, Elcelyx announced the formation of NaZura BioHealth Inc, a separate company established to focus on the development on non-NewMet assets. Elcelyx is headquartered in San Diego, California.
KAIAM is a private company that specializes in the design and manufacture of photonic integrated circuits and optical components aimed at high-speed data transfer. The company develops gadgets that facilitate the transmission and reception of data at very high speeds, catering primarily to the needs of computer networking and hyper-scale data centers. KAIAM produces a range of products, including optical sub-assemblies, modules, and transceivers, utilizing advanced technologies such as micromachined silicon. One of their notable innovations is the CWDM4, a 100 Gigabit-per-second coarse wavelength division multiplexing transceiver, which highlights their commitment to delivering high-quality optical networking solutions for various applications in the fiber optics communications industry.
CoalTek, Inc. specializes in producing high-quality coal by transforming lower-grade coal into a more efficient energy fuel with reduced environmental impact. The company employs a unique volumetric heating technology that selectively targets the moisture content in coal, using significantly less energy compared to traditional thermal methods. This innovative approach not only enhances plant efficiency but also ensures compliance with environmental standards. Founded in 1998 and headquartered in Tucker, Georgia, CoalTek operates a commercial processing facility in Calvert City, Kentucky, which began operations in 2006 with an initial capacity of 120,000 tons per year. The company plans to expand this facility and establish additional sites to accommodate the increasing demand for cleaner coal solutions. Dr. Jerry Weinberg, a co-founder, and chief geologist Neil Ginther played crucial roles in developing and validating the technology over eight years.
ForSight VISION5, founded in 2010 as part of ForSight Labs, specializes in developing innovative drug delivery technologies aimed at treating various eye conditions. The company focuses on creating non-invasive products designed to replace traditional eye drops, offering sustained therapy for significant eye diseases such as glaucoma, dry eye, and allergies. Currently, ForSight VISION5 is in its second Phase 2 clinical study for its lead product, the Helios insert, which represents a significant advancement in ocular treatment options.
ForSight Labs is dedicated to developing innovative ophthalmic technologies aimed at enhancing the sight and quality of life for visually impaired patients. The organization collaborates with entrepreneurs, investors, and clinicians to drive advancements in eye care through the creation and commercialization of high-impact solutions. With millions of individuals in the U.S. suffering from vision impairment and the associated economic burden exceeding $50 billion annually, ForSight Labs addresses a significant public health challenge. Their focus includes developing treatments for conditions such as glaucoma, which can lead to irreversible blindness in adults. By fostering a creative and cooperative environment, ForSight Labs strives to deliver effective solutions to the ophthalmic community and the patients it serves.
Scioderm, LLC is a clinical-stage pharmaceutical company based in Durham, North Carolina, specializing in the research, development, and manufacture of drugs for chronic skin diseases, particularly epidermolysis bullosa (EB). Founded in 2012, the company is focused on creating topical therapies to meet significant medical needs in the dermatological field. Its primary investigational product, Zorblisa, is designed to treat the skin blistering and lesions associated with EB, a rare inherited disorder characterized by fragile skin. Zorblisa aims to facilitate the healing of existing skin lesions while reducing the frequency and severity of new lesions. As of September 2015, Scioderm operates as a subsidiary of Amicus Therapeutics, Inc.
Tonix Pharmaceuticals is a clinical-stage biopharmaceutical company based in New York, focused on the development of small molecules and biologics to treat and prevent various human diseases. The company has a diverse portfolio that includes immunology products, such as vaccines for infectious diseases and biologics aimed at treating immunosuppression, cancer, and autoimmune disorders. Notably, its lead vaccine candidate, TNX-1800, is designed to protect against COVID-19, while other candidates like TNX-801 and TNX-2300 target smallpox, monkeypox, and additional COVID-19 prevention. In the central nervous system (CNS) domain, Tonix's leading candidate, TNX-102 SL, is in Phase 3 development for fibromyalgia and is also being studied for agitation in Alzheimer’s disease and alcohol use disorder. Other CNS candidates include TNX-1300 for cocaine intoxication, TNX-601 CR for depression, and TNX-1900 for migraines. The preclinical pipeline features promising treatments for conditions like post-traumatic stress disorder and cancer. Founded in 2007, Tonix is dedicated to addressing critical health needs through its innovative therapeutic approaches.
Akros Silicon Inc. is a fabless semiconductor company specializing in power management integrated circuits (ICs) designed for remote network-based energy management applications. Founded in 2005 and headquartered in San Jose, California, with an office in Shanghai, the company develops system-level solutions using precision analog and mixed-signal CMOS technologies. Its product offerings include isolated DC-DC system-on-a-chip solutions, power-over-Ethernet powered device controllers, and digital isolators. Akros Silicon's technologies, such as its GreenEdge digital isolation, facilitate the integration of power systems without traditional isolation barriers. The company’s solutions are utilized in a variety of applications, including Ethernet switches, solar microinverters, VoIP phones, and industrial equipment. Akros Silicon markets its products through representatives across multiple regions, including North America, Europe, and Asia. As of 2015, it operates as a subsidiary of Kinetic Technologies HK Limited.
TRIA Beauty, Inc. specializes in the development and marketing of light-based medical devices designed for consumer use in skincare and beauty treatments. The company offers a range of products, including a hand-held diode laser for hair removal, a blue light device targeting acne-causing bacteria, a fractional non-ablative laser for skin rejuvenation, and an eye wrinkle correcting laser. These devices provide effective solutions that allow users to achieve professional results at home. TRIA Beauty's products are available through its e-commerce platform and various retail channels, including television and physical stores, across multiple regions, including the United States, Japan, and several European countries. Founded in 2003 and headquartered in Dublin, California, TRIA Beauty was previously known as SpectraGenics, Inc. before rebranding in 2008.
Akros Silicon Inc. is a fabless semiconductor company specializing in power management integrated circuits (ICs) designed for remote network-based energy management applications. Founded in 2005 and headquartered in San Jose, California, with an office in Shanghai, the company develops system-level solutions using precision analog and mixed-signal CMOS technologies. Its product offerings include isolated DC-DC system-on-a-chip solutions, power-over-Ethernet powered device controllers, and digital isolators. Akros Silicon's technologies, such as its GreenEdge digital isolation, facilitate the integration of power systems without traditional isolation barriers. The company’s solutions are utilized in a variety of applications, including Ethernet switches, solar microinverters, VoIP phones, and industrial equipment. Akros Silicon markets its products through representatives across multiple regions, including North America, Europe, and Asia. As of 2015, it operates as a subsidiary of Kinetic Technologies HK Limited.
Elcelyx was founded in 2010 with venture capital backing based on Gut Sensory Modulation (GSM) technology. Elcelyx’s proprietary, first-in-class Gut Sensory Modulators are delivered directly to the lower gut where they act on molecular targets to elicit physiological and pharmacological effects. The Elcelyx proprietary product candidate, NewMet for Type 2 diabetes is entering Phase 2b development and is a blockbuster opportunity designed to address the unmet needs in the oral anti-diabetic market. Elcelyx is led by an experienced management team and Board of Directors with track records of success in drug development and commercialization. Premier investors along with seasoned scientists and clinicians support the team. In September 2013, Elcelyx announced the formation of NaZura BioHealth Inc, a separate company established to focus on the development on non-NewMet assets. Elcelyx is headquartered in San Diego, California.
Benvenue Medical, Inc. specializes in the design, manufacturing, and marketing of minimally invasive expandable implant systems for treating spinal disorders, specifically vertebral compression fractures and degenerative disc diseases. The company offers products such as the Kiva system, which addresses spinal fractures in the thoracic and lumbar regions, and the Blazer – C system, aimed at treating various types of pathological vertebral compression fractures. Additionally, Benvenue Medical has introduced the Luna 3D, an expandable interbody fusion system designed for use in minimally invasive, mini-open, or open surgical procedures. Established in 2004 and headquartered in Santa Clara, California, the company serves a diverse customer base in the United States, Canada, Belgium, France, and Germany.
Transcend Medical, Inc. is an ophthalmic device company dedicated to developing medical devices for the treatment of glaucoma, a leading cause of irreversible blindness in adults. Founded in 2005 and based in Menlo Park, California, the company emerged from ForSight Labs and focuses on minimally invasive solutions to replace traditional invasive therapies. Its flagship product, the CyPass Micro-Stent, is designed to be inserted during routine cataract surgery to help reduce intraocular pressure. Transcend Medical also offers the Vold Gonio Lens for use in micro-invasive glaucoma surgery and provides clinical trial services. The CyPass Micro-Stent received CE mark approval in 2008 and has been evaluated in various clinical studies, including the COMPASS multi-center trial. The company operates as a subsidiary of Alcon Holdings, Inc.
Medley Health is an innovative, entrepreneurial, technology-driven company. It's backed by top-tier investors and a management team with deep business expertise in healthcare, Internet and web services, as well as next-generation communications technologies.
Transcend Medical, Inc. is an ophthalmic device company dedicated to developing medical devices for the treatment of glaucoma, a leading cause of irreversible blindness in adults. Founded in 2005 and based in Menlo Park, California, the company emerged from ForSight Labs and focuses on minimally invasive solutions to replace traditional invasive therapies. Its flagship product, the CyPass Micro-Stent, is designed to be inserted during routine cataract surgery to help reduce intraocular pressure. Transcend Medical also offers the Vold Gonio Lens for use in micro-invasive glaucoma surgery and provides clinical trial services. The CyPass Micro-Stent received CE mark approval in 2008 and has been evaluated in various clinical studies, including the COMPASS multi-center trial. The company operates as a subsidiary of Alcon Holdings, Inc.
Revance Therapeutics, Inc. is a biotechnology company focused on the development, manufacture, and commercialization of neuromodulators for aesthetic and therapeutic uses. The company’s lead product, DaxibotulinumtoxinA for injection (DAXI), is undergoing clinical trials for various conditions, including glabellar lines, cervical dystonia, adult upper limb spasticity, and chronic migraine. In addition, DAXI is being evaluated for cosmetic applications such as forehead lines and lateral canthal lines. Revance is also developing DaxibotulinumtoxinA Topical for both therapeutic and aesthetic purposes, and it is working on a biosimilar to BOTOX in collaboration with Mylan. Founded in 1999 and originally known as Essentia Biosystems, the company is headquartered in Newark, California.
Benvenue Medical, Inc. specializes in the design, manufacturing, and marketing of minimally invasive expandable implant systems for treating spinal disorders, specifically vertebral compression fractures and degenerative disc diseases. The company offers products such as the Kiva system, which addresses spinal fractures in the thoracic and lumbar regions, and the Blazer – C system, aimed at treating various types of pathological vertebral compression fractures. Additionally, Benvenue Medical has introduced the Luna 3D, an expandable interbody fusion system designed for use in minimally invasive, mini-open, or open surgical procedures. Established in 2004 and headquartered in Santa Clara, California, the company serves a diverse customer base in the United States, Canada, Belgium, France, and Germany.
Alta Devices, Inc., founded in 2007 and based in Sunnyvale, California, specializes in the manufacture of high-efficiency solar technology, specifically single junction solar cells. The company develops thin and flexible mobile power solutions for various applications, including unmanned systems, consumer electronics, sensors, automotive, remote exploration, wearables, and Internet of Things devices. As a development-stage company, Alta Devices aims to enhance the production economics of solar photovoltaic applications and has attracted venture capital funding from notable investors. As of February 2015, it operates as a subsidiary of Hanergy Hi-Tech Power (HK) Limited.
TRIA Beauty, Inc. specializes in the development and marketing of light-based medical devices designed for consumer use in skincare and beauty treatments. The company offers a range of products, including a hand-held diode laser for hair removal, a blue light device targeting acne-causing bacteria, a fractional non-ablative laser for skin rejuvenation, and an eye wrinkle correcting laser. These devices provide effective solutions that allow users to achieve professional results at home. TRIA Beauty's products are available through its e-commerce platform and various retail channels, including television and physical stores, across multiple regions, including the United States, Japan, and several European countries. Founded in 2003 and headquartered in Dublin, California, TRIA Beauty was previously known as SpectraGenics, Inc. before rebranding in 2008.
Incline Therapeutics is a privately-held specialty pharmaceutical company that focuses on the development of IONSYS, a fentanyl iontophoretic transdermal system designed for adult inpatients needing opioid pain relief following surgery. The company is dedicated to creating a compact, disposable, needleless Patient-Controlled Analgesia system that facilitates the short-term management of postoperative pain. Incline Therapeutics is backed by prominent life science venture capital firms and is led by a management team with extensive experience in the pharmaceutical and medical device sectors.
Revance Therapeutics, Inc. is a biotechnology company focused on the development, manufacture, and commercialization of neuromodulators for aesthetic and therapeutic uses. The company’s lead product, DaxibotulinumtoxinA for injection (DAXI), is undergoing clinical trials for various conditions, including glabellar lines, cervical dystonia, adult upper limb spasticity, and chronic migraine. In addition, DAXI is being evaluated for cosmetic applications such as forehead lines and lateral canthal lines. Revance is also developing DaxibotulinumtoxinA Topical for both therapeutic and aesthetic purposes, and it is working on a biosimilar to BOTOX in collaboration with Mylan. Founded in 1999 and originally known as Essentia Biosystems, the company is headquartered in Newark, California.
EmSense Corporation provides scalable physiological and brainwave measurement technology. Its EmSense headset measures brainwave cognition and emotion on a moment by moment basis as consumers are exposed to advertising, video games, political messaging, movies, and TV shows, as well as incorporates physiological sensors that measure viewers' blinking, breathing, and physical motion to their heart activity and moments when they blush. The company was founded in 2004 and is based in San Francisco, California with additional offices in Monterey and Santa Monica, California.
Transcend Medical, Inc. is an ophthalmic device company dedicated to developing medical devices for the treatment of glaucoma, a leading cause of irreversible blindness in adults. Founded in 2005 and based in Menlo Park, California, the company emerged from ForSight Labs and focuses on minimally invasive solutions to replace traditional invasive therapies. Its flagship product, the CyPass Micro-Stent, is designed to be inserted during routine cataract surgery to help reduce intraocular pressure. Transcend Medical also offers the Vold Gonio Lens for use in micro-invasive glaucoma surgery and provides clinical trial services. The CyPass Micro-Stent received CE mark approval in 2008 and has been evaluated in various clinical studies, including the COMPASS multi-center trial. The company operates as a subsidiary of Alcon Holdings, Inc.
Visiogen, Inc. is an ophthalmic medical device company focused on creating innovative vision solutions for patients suffering from cataracts, including those with presbyopia. The company has developed the Synchrony dual optic accommodating intraocular lens (IOL), which aims to enhance visual clarity at near, intermediate, and distance ranges without requiring glasses or contact lenses. To streamline the surgical process, the Synchrony IOL is offered in a pre-loaded injector, minimizing lens handling during implantation. This patented technology has received CE Mark approval in Europe and is currently in clinical trials in the United States.
PowerGenix develops and manufactures nickel-zinc rechargeable batteries and chargers for power-intensive electronics, toys, power tools, and hybrid electric vehicles. The company’s products are used in cordless power tools, UPS systems, electric scooters, specialty military equipment, and high-intensity DC lighting; military starting, lighting, and ignition vehicles; silent watches; equipment actuation; hybrid-electric propulsion systems; and consumer electronic devices and batteries. It supplies its products to original equipment manufacturers globally. PowerGenix was founded in 2000 and is headquartered in San Diego, California, United States with an additional manufacturing facility in Shenzhen, China.
BrainCells develops and provides biopharmaceutical products for the treatment of central nervous system (CNS) diseases. It develops compounds that promote the growth of new neurons for the treatment of major depressive disorder (MDD), treatment resistant depression (TRD), and potentially Alzheimer’s disease (AD). The company's products include BCI-838 and BCI-632 which increase synaptic glutamate by inhibiting the mGlu2/3 auto-receptor. The company also builds a pipeline of clinical-stage programs to address unmet medical needs in the treatment of mood disorders, psychoses, cognition, brain repair syndromes, and other CNS disorders. The company was founded in 2003 and is based in San Diego, California.
Revance Therapeutics, Inc. is a biotechnology company focused on the development, manufacture, and commercialization of neuromodulators for aesthetic and therapeutic uses. The company’s lead product, DaxibotulinumtoxinA for injection (DAXI), is undergoing clinical trials for various conditions, including glabellar lines, cervical dystonia, adult upper limb spasticity, and chronic migraine. In addition, DAXI is being evaluated for cosmetic applications such as forehead lines and lateral canthal lines. Revance is also developing DaxibotulinumtoxinA Topical for both therapeutic and aesthetic purposes, and it is working on a biosimilar to BOTOX in collaboration with Mylan. Founded in 1999 and originally known as Essentia Biosystems, the company is headquartered in Newark, California.
Imperium Renewables, Inc., together with its subsidiary, produces and markets biodiesel in the United States. The company produces biodiesel from feedstock oils; and glycerin, a by-product of biodiesel. Its biodiesel is used as alternative fuel in cars, trucks, ships, trains, and planes. The company markets its products through a network of distributors. Imperium Renewables, Inc. was formerly known as Seattle Biodiesel, LLC and changed its name to Imperium Renewables, Inc. in May 2005. The company was founded in 2004 and is based in Seattle, Washington. It has production facilities in Hoquiam, Washington; and Oahu, Hawaii.
ITM Software delivers the only truly integrated approach to IT Business Management - one solution and one system of record for comprehensive visibility, coordination and control across IT functions. Serving as the glue connecting the traditional silos of IT information, ITM enables increased transparency, better decisions, more effective spending, and improved business alignment. The company has a single focus on serving the business management needs of IT organizations. Lead by former CIOs and IT leaders, ITM Software brings a unique perspective to the management challenges facing IT today. This experience base, combined with a world-class software development team, translates into products and best-practice expertise that bring a business-centric approach to managing IT. At the core of the ITM offering is the ITM Business Suite, an integrated solution comprised of six components addressing the most critical areas of IT Business Management including people, processes, vendors, assets, financials, projects, and regulatory compliance. Coupled with the ITM Business Suite, the company provides best practice expertise and a proven methodology for helping clients define business objectives and develop and execute on a plan to achieve them. This unique combination of software products and management expertise enables CIOs to drive down IT costs, and increase the bottom line through improved alignment with the business objectives of the enterprise. Founded in 2001 by former CIOs, the Company serves IT organizations within Fortune 2000 corporations, government agencies and universities. ITM Software is privately held and is headquartered in Mountain View, California.
Leptos Biomedical offers a proprietary neuromodulation therapy solution for chronic obesity. The company delivers its treatment, which involves the electrical activation of a nerve in the autonomic nervous system via a pacemaker-type device. Leptos Biomedical was founded in 2002 and is based in Fridley, Minnesota.
TRIA Beauty, Inc. specializes in the development and marketing of light-based medical devices designed for consumer use in skincare and beauty treatments. The company offers a range of products, including a hand-held diode laser for hair removal, a blue light device targeting acne-causing bacteria, a fractional non-ablative laser for skin rejuvenation, and an eye wrinkle correcting laser. These devices provide effective solutions that allow users to achieve professional results at home. TRIA Beauty's products are available through its e-commerce platform and various retail channels, including television and physical stores, across multiple regions, including the United States, Japan, and several European countries. Founded in 2003 and headquartered in Dublin, California, TRIA Beauty was previously known as SpectraGenics, Inc. before rebranding in 2008.
Tesla, Inc. designs, develops, manufactures, leases, and sells electric vehicles and energy generation and storage systems globally, including in the United States, China, and Europe. The company operates in two main segments: Automotive and Energy Generation and Storage. The Automotive segment offers a range of electric vehicles, including sedans and SUVs, and provides electric powertrain components and related services through its service locations and mobile technicians. It sells its vehicles through company-owned stores and its website. The Energy Generation and Storage segment focuses on energy storage solutions, such as lithium-ion battery systems for homes and commercial applications, and includes the design and installation of solar energy products. Tesla also offers vehicle insurance and promotes renewable energy solutions. Founded in 2003 and headquartered in Palo Alto, California, the company aims to accelerate the world’s transition to electric mobility by expanding the availability and affordability of electric vehicles.
Nfocus Neuromedical
Series B in 2007
Nfocus Neuromedical, Inc. designs, develops, and markets endovascular neurosurgery solutions to cure intracranial aneurysms. The company offers revolutionary systems to treat neurovascular disease, including brain aneurysms. The company was formerly known as CardioVasc, Inc. and changed its name to Nfocus Neuromedical, Inc. in April 2007. The company was incorporated in 1997 and is based in Palo Alto, California. As of February 19, 2013, Nfocus Neuromedical, Inc. operates as a subsidiary of Covidien plc.
Accelergy is a global leader in producing a direct replacement, low carbon, synthetic distillate liquids, and transportation fuels at a lower cost to both the environment and to the consumer. Accelergy uses domestic, carbon-based resources such as natural gas and biomass to produce cost-competitive liquids with a reduced CO2 footprint compared to traditional petroleum-based products. They do this without the expensive infrastructure required by many other alternative synthetics technologies.
The company was founded in 2003 and headquartered in Houston, Texas.
PowerGenix develops and manufactures nickel-zinc rechargeable batteries and chargers for power-intensive electronics, toys, power tools, and hybrid electric vehicles. The company’s products are used in cordless power tools, UPS systems, electric scooters, specialty military equipment, and high-intensity DC lighting; military starting, lighting, and ignition vehicles; silent watches; equipment actuation; hybrid-electric propulsion systems; and consumer electronic devices and batteries. It supplies its products to original equipment manufacturers globally. PowerGenix was founded in 2000 and is headquartered in San Diego, California, United States with an additional manufacturing facility in Shenzhen, China.
CoalTek, Inc. specializes in producing high-quality coal by transforming lower-grade coal into a more efficient energy fuel with reduced environmental impact. The company employs a unique volumetric heating technology that selectively targets the moisture content in coal, using significantly less energy compared to traditional thermal methods. This innovative approach not only enhances plant efficiency but also ensures compliance with environmental standards. Founded in 1998 and headquartered in Tucker, Georgia, CoalTek operates a commercial processing facility in Calvert City, Kentucky, which began operations in 2006 with an initial capacity of 120,000 tons per year. The company plans to expand this facility and establish additional sites to accommodate the increasing demand for cleaner coal solutions. Dr. Jerry Weinberg, a co-founder, and chief geologist Neil Ginther played crucial roles in developing and validating the technology over eight years.
BioTrove, Inc. specializes in micro and nano-scale technology platforms aimed at advancing life science and drug discovery research. The company has developed innovative systems that include the OpenArray platform, which facilitates relative gene expression analysis to support genomic research across various fields such as agriculture, disease research, and public health. Additionally, BioTrove offers the RapidFire platform, designed for screening difficult drug targets through mass spectrometry-based assay development, alongside its RapidFire mass spectrometry hardware system that serves as a native detection technology for drug screening and in vitro absorption, distribution, metabolism, and excretion (ADME) applications. These technologies enable rapid and efficient analysis, enhancing the research process and fostering development in molecular diagnostics and high-throughput screening.
NanoGram Corporation specializes in the development and manufacturing of advanced products for photovoltaics, electronics, and displays, leveraging its expertise in nanotechnology. The company offers a customized nanotechnology platform that produces application-specific nanomaterials and nanoscale compositions tailored for various sectors, including optical, electronic, imaging, biomedical, and energy applications. With a presence in Japan through its Tokyo office and a strategic partnership with Nagase & Co., Ltd, as well as a Seoul office to address the Korean market, NanoGram is poised to capitalize on growth opportunities in Asia. Additionally, NanoGram has successfully incubated and spun out two companies, enhancing its innovation footprint in the nanotechnology sector.
eNeura Inc. is a medical technology company focused on developing portable, non-invasive transcranial magnetic stimulation (TMS) devices for the treatment and prevention of migraines. Its flagship product, the sTMS mini, utilizes single-pulse TMS to provide migraine relief by generating targeted magnetic fields that pass through bone and tissue. This device is designed for both acute and prophylactic treatment of migraines in adolescents aged 12 and older, as well as adults, allowing for convenient use at home or on the go. eNeura was established in 2012 and is headquartered in San Jose, California, with an additional office in Baltimore, Maryland. The company, formerly known as eNeura Therapeutics LLC, rebranded in February 2014. However, it faced financial difficulties and filed for liquidation under Chapter 7 in August 2020.
Sensicore, Inc. develops smart sensor systems and sensor networks that automate water testing, data collection, and analysis for drinking and industrial applications. It offers WaterPOINT, a handheld screening tool and water tester that provides a profile of various chemistry measurements, allowing users to conduct various tests at sites, as well as allows municipalities to manage resources; and WaterNOW, a Web-based data visualization, analysis, and decision support system that enable users to manage water system and data collected by WaterPOINT and other sources. The company also provides sensor kits and bundles, which include disinfection and disinfection/DPD chlorine drinking water test kits, and basic water test kits; and colorimetric test kits, including aluminum, bromine, chloride, copper, cyanide, fluoride, iron, manganese, molybdate, nitrate, nitrite, ortho-phosphate, silica, sulfate, sulfide, and zinc vacuum ampoules. In addition, the company offers accessories, such as portable thermal printers, communications cables, power inverters, and power supply products. It offers products for measuring and monitoring water quality, including incoming water quality and boiler feed monitoring; cooling tower monitoring and process control; filtration system performance monitoring; cleaning and rinse control system monitoring; product testing and control; and food and beverage applications. The company was founded in 2000 and is based in Ann Arbor, Michigan. As of March 31, 2008, Sensicore, Inc. operates as a subsidiary of GE Analytical Instruments, Inc.
CoalTek, Inc. specializes in producing high-quality coal by transforming lower-grade coal into a more efficient energy fuel with reduced environmental impact. The company employs a unique volumetric heating technology that selectively targets the moisture content in coal, using significantly less energy compared to traditional thermal methods. This innovative approach not only enhances plant efficiency but also ensures compliance with environmental standards. Founded in 1998 and headquartered in Tucker, Georgia, CoalTek operates a commercial processing facility in Calvert City, Kentucky, which began operations in 2006 with an initial capacity of 120,000 tons per year. The company plans to expand this facility and establish additional sites to accommodate the increasing demand for cleaner coal solutions. Dr. Jerry Weinberg, a co-founder, and chief geologist Neil Ginther played crucial roles in developing and validating the technology over eight years.
NeuroPace, Inc. specializes in the design, development, manufacturing, and marketing of implantable devices aimed at treating neurological disorders through responsive stimulation. The company's flagship product, the RNS System, is specifically designed for patients with medically refractory partial epilepsy. This system includes a small implantable neurostimulator that monitors brain activity and delivers electrical pulses to targeted areas to prevent seizures. The RNS System comprises various components, such as depth leads and cortical strip leads for implantation, along with external devices like a programmer that allows healthcare professionals to communicate with the neurostimulator. Founded in 1997, NeuroPace is headquartered in Mountain View, California.
ITM Software delivers the only truly integrated approach to IT Business Management - one solution and one system of record for comprehensive visibility, coordination and control across IT functions. Serving as the glue connecting the traditional silos of IT information, ITM enables increased transparency, better decisions, more effective spending, and improved business alignment. The company has a single focus on serving the business management needs of IT organizations. Lead by former CIOs and IT leaders, ITM Software brings a unique perspective to the management challenges facing IT today. This experience base, combined with a world-class software development team, translates into products and best-practice expertise that bring a business-centric approach to managing IT. At the core of the ITM offering is the ITM Business Suite, an integrated solution comprised of six components addressing the most critical areas of IT Business Management including people, processes, vendors, assets, financials, projects, and regulatory compliance. Coupled with the ITM Business Suite, the company provides best practice expertise and a proven methodology for helping clients define business objectives and develop and execute on a plan to achieve them. This unique combination of software products and management expertise enables CIOs to drive down IT costs, and increase the bottom line through improved alignment with the business objectives of the enterprise. Founded in 2001 by former CIOs, the Company serves IT organizations within Fortune 2000 corporations, government agencies and universities. ITM Software is privately held and is headquartered in Mountain View, California.
PolyFuel, Inc. is a company that designs, develops, engineers, and manufactures portable fuel cells aimed at enhancing the performance of electronic devices. Founded in 1999 and headquartered in Mountain View, California, PolyFuel focuses on creating advanced membranes and systems to address the power deficiencies in portable electronics. The company's innovations are intended to improve the efficiency and functionality of electronic-based products, catering to the growing demand for reliable and sustainable power solutions.
Revance Therapeutics, Inc. is a biotechnology company focused on the development, manufacture, and commercialization of neuromodulators for aesthetic and therapeutic uses. The company’s lead product, DaxibotulinumtoxinA for injection (DAXI), is undergoing clinical trials for various conditions, including glabellar lines, cervical dystonia, adult upper limb spasticity, and chronic migraine. In addition, DAXI is being evaluated for cosmetic applications such as forehead lines and lateral canthal lines. Revance is also developing DaxibotulinumtoxinA Topical for both therapeutic and aesthetic purposes, and it is working on a biosimilar to BOTOX in collaboration with Mylan. Founded in 1999 and originally known as Essentia Biosystems, the company is headquartered in Newark, California.
Accelergy is a global leader in producing a direct replacement, low carbon, synthetic distillate liquids, and transportation fuels at a lower cost to both the environment and to the consumer. Accelergy uses domestic, carbon-based resources such as natural gas and biomass to produce cost-competitive liquids with a reduced CO2 footprint compared to traditional petroleum-based products. They do this without the expensive infrastructure required by many other alternative synthetics technologies.
The company was founded in 2003 and headquartered in Houston, Texas.
Saegis Pharmaceuticals is dedicated to developing medications aimed at treating behavioral disorders linked to central nervous system (CNS) diseases. The company has a robust pipeline targeting cognitive dysfunction related to conditions such as Alzheimer’s disease, mild cognitive impairment, attention deficit hyperactivity disorder, and cognitive impairment associated with schizophrenia. By focusing on therapeutics for patients experiencing memory loss and cognitive deficits due to aging, psychiatric disorders, and brain injuries, Saegis Pharmaceuticals seeks to address significant challenges in mental health and cognitive health. Founded in 1999, the company is headquartered in Half Moon Bay, California.
ITM Software delivers the only truly integrated approach to IT Business Management - one solution and one system of record for comprehensive visibility, coordination and control across IT functions. Serving as the glue connecting the traditional silos of IT information, ITM enables increased transparency, better decisions, more effective spending, and improved business alignment. The company has a single focus on serving the business management needs of IT organizations. Lead by former CIOs and IT leaders, ITM Software brings a unique perspective to the management challenges facing IT today. This experience base, combined with a world-class software development team, translates into products and best-practice expertise that bring a business-centric approach to managing IT. At the core of the ITM offering is the ITM Business Suite, an integrated solution comprised of six components addressing the most critical areas of IT Business Management including people, processes, vendors, assets, financials, projects, and regulatory compliance. Coupled with the ITM Business Suite, the company provides best practice expertise and a proven methodology for helping clients define business objectives and develop and execute on a plan to achieve them. This unique combination of software products and management expertise enables CIOs to drive down IT costs, and increase the bottom line through improved alignment with the business objectives of the enterprise. Founded in 2001 by former CIOs, the Company serves IT organizations within Fortune 2000 corporations, government agencies and universities. ITM Software is privately held and is headquartered in Mountain View, California.
Sensicore, Inc. develops smart sensor systems and sensor networks that automate water testing, data collection, and analysis for drinking and industrial applications. It offers WaterPOINT, a handheld screening tool and water tester that provides a profile of various chemistry measurements, allowing users to conduct various tests at sites, as well as allows municipalities to manage resources; and WaterNOW, a Web-based data visualization, analysis, and decision support system that enable users to manage water system and data collected by WaterPOINT and other sources. The company also provides sensor kits and bundles, which include disinfection and disinfection/DPD chlorine drinking water test kits, and basic water test kits; and colorimetric test kits, including aluminum, bromine, chloride, copper, cyanide, fluoride, iron, manganese, molybdate, nitrate, nitrite, ortho-phosphate, silica, sulfate, sulfide, and zinc vacuum ampoules. In addition, the company offers accessories, such as portable thermal printers, communications cables, power inverters, and power supply products. It offers products for measuring and monitoring water quality, including incoming water quality and boiler feed monitoring; cooling tower monitoring and process control; filtration system performance monitoring; cleaning and rinse control system monitoring; product testing and control; and food and beverage applications. The company was founded in 2000 and is based in Ann Arbor, Michigan. As of March 31, 2008, Sensicore, Inc. operates as a subsidiary of GE Analytical Instruments, Inc.
Storability Software is a provider of enterprise storage resource management solutions that simplify and centralize the management of complex, multi-site, multi-vendor storage infrastructures. Storability Software's Global Storage Manager is an open standards-based solution that enables customers to comprehend, control, and capitalize on their storage investment as never before. Customers benefit from increased asset utilization, improved management efficiency, enhanced quality of service, and higher availability.
Rinat Neuroscience, founded in 2001 following a spin-out from Genentech, focuses on developing protein-based therapeutics for various neurological diseases and disorders. The company leverages significant research and development resources previously invested by Genentech to advance its pioneering efforts in antibody drug development. Rinat is dedicated to creating innovative treatments for conditions such as pain, Alzheimer's disease, obesity, diabetes, and neuropathies. Additionally, it is engaged in developing novel therapies aimed at modifying disease progression by targeting and protecting specific populations of neurons affected by these diseases. Through its work, Rinat Neuroscience seeks to improve patient outcomes in the field of neurology.
Iomai Corporation discovers and develops vaccines and immune system stimulants, delivered via a novel, needle-free technology called transcutaneous immunization (TCI). TCI taps into the unique benefits of a major group of antigen-presenting cells found in the outer layers of the skin to generate an enhanced immune response. Iomai is leveraging TCI to enhance the efficacy of existing vaccines, enable new vaccines that are viable only through transcutaneous administration and expand the global vaccine market. The company was incorporated in 1997 and is based in Gaithersburg, Maryland. Intercell USA, Inc. was formerly known as Iomai Corporation. As a result of the acquisition of Iomai Corporation by Intercell Ag, Iomai Corporation's name was changed. As of August 5, 2008, Intercell USA, Inc. operates as a subsidiary of Intercell Biomedical Research & Development AG.
Datria provides packaged mobility solutions that voice-enable existing/new business processes. Workers use their existing phones or VoIP-capable devices to exchange information in real-time with all corporate systems.
PolyFuel, Inc. is a company that designs, develops, engineers, and manufactures portable fuel cells aimed at enhancing the performance of electronic devices. Founded in 1999 and headquartered in Mountain View, California, PolyFuel focuses on creating advanced membranes and systems to address the power deficiencies in portable electronics. The company's innovations are intended to improve the efficiency and functionality of electronic-based products, catering to the growing demand for reliable and sustainable power solutions.
Storability Software is a provider of enterprise storage resource management solutions that simplify and centralize the management of complex, multi-site, multi-vendor storage infrastructures. Storability Software's Global Storage Manager is an open standards-based solution that enables customers to comprehend, control, and capitalize on their storage investment as never before. Customers benefit from increased asset utilization, improved management efficiency, enhanced quality of service, and higher availability.
eNeura Inc. is a medical technology company focused on developing portable, non-invasive transcranial magnetic stimulation (TMS) devices for the treatment and prevention of migraines. Its flagship product, the sTMS mini, utilizes single-pulse TMS to provide migraine relief by generating targeted magnetic fields that pass through bone and tissue. This device is designed for both acute and prophylactic treatment of migraines in adolescents aged 12 and older, as well as adults, allowing for convenient use at home or on the go. eNeura was established in 2012 and is headquartered in San Jose, California, with an additional office in Baltimore, Maryland. The company, formerly known as eNeura Therapeutics LLC, rebranded in February 2014. However, it faced financial difficulties and filed for liquidation under Chapter 7 in August 2020.
NightFire Software specializes in order management solutions for the telecommunications industry, focusing on automating the service supply chain. Its flagship product, NetServ Express, streamlines the ordering process for competitive service providers, enabling them to deliver services efficiently and cost-effectively in a deregulated market. The company enhances the operational capabilities of telecommunications providers by simplifying interactions between retailers and wholesalers, thereby reducing management burdens. In addition to its core software offerings, NightFire provides a range of services, including customer environment analysis, installation, connectivity testing, and post-implementation support. This comprehensive approach ensures that clients receive ongoing assistance, training, and software updates, facilitating smooth operations and adaptability in a dynamic industry.
Storability Software is a provider of enterprise storage resource management solutions that simplify and centralize the management of complex, multi-site, multi-vendor storage infrastructures. Storability Software's Global Storage Manager is an open standards-based solution that enables customers to comprehend, control, and capitalize on their storage investment as never before. Customers benefit from increased asset utilization, improved management efficiency, enhanced quality of service, and higher availability.
Spinal Dynamics
Series B in 2001
Spinal Dynamics develops neuro-surgical devices for the replacement of spinal disks. The company's Bryan Cervical Disc System is an implanted prosthesis designed to replace and mimic the flexibility and shock-absorbing characteristics of natural intervertebral discs. It features a shock-absorbing elastomer that is intended to cushion the vertebrae and allow movement of the head and neck and is designed to replace the disc that is removed from the patient in cervical spine surgery.
Rinat Neuroscience, founded in 2001 following a spin-out from Genentech, focuses on developing protein-based therapeutics for various neurological diseases and disorders. The company leverages significant research and development resources previously invested by Genentech to advance its pioneering efforts in antibody drug development. Rinat is dedicated to creating innovative treatments for conditions such as pain, Alzheimer's disease, obesity, diabetes, and neuropathies. Additionally, it is engaged in developing novel therapies aimed at modifying disease progression by targeting and protecting specific populations of neurons affected by these diseases. Through its work, Rinat Neuroscience seeks to improve patient outcomes in the field of neurology.
APX has continuously provided innovative technology and service solutions for the energy and environmental markets. Their business experience spans transaction management, registries, scheduling, settlements, demand-side management, asset control, analytics, operations, exchanges, clearing, and brokerage. They continue to leverage their deep domain and technological expertise, providing focused solutions for their clients in the energy and environmental markets. This depth and breadth of knowledge makes the APX team uniquely qualified to provide leading-edge market solutions that deliver trust, integrity, and experience.
Encirq solves marketing's #1 challenge: Delivering Personalization with Privacy™. Encirq is an online marketing services company that has developed a unique data engine to deliver individualized, consumer-centered marketing over the Internet. We use online and offline, real-time individual transactional data in a private and secure environment. Marketers and Encirq cannot see the data. Rather, the data reside on each consumer's personal computer, and filter out marketing messages that are not relevant. The service and technology are extendible to broadband, to other network devices, and eventually can be used to deliver personalized television commercials to individual households. Encirq's data engine does two things: It provides cost-effective access to consumer information not previously available; and it enables personalized real-time marketing programs. We have filed multiple patent applications on Encirq's illumination processes and technology.
APX has continuously provided innovative technology and service solutions for the energy and environmental markets. Their business experience spans transaction management, registries, scheduling, settlements, demand-side management, asset control, analytics, operations, exchanges, clearing, and brokerage. They continue to leverage their deep domain and technological expertise, providing focused solutions for their clients in the energy and environmental markets. This depth and breadth of knowledge makes the APX team uniquely qualified to provide leading-edge market solutions that deliver trust, integrity, and experience.
E-LOAN is a nationwide financial services company that is dedicated to providing consumers with a simple, easy and open way to obtain high yield savings accounts and CDs. Their web site also provides access to several preferred, nationally recognized lending partners that may be able to assist you in obtaining a loan that meets your financial needs. Since its launch in 1997, E-LOAN has drawn upon its pro consumer values to deliver their customers the best online experience possible.
SkillsVillage.com provides a blended model of applications and services across the entire procurement lifecycle for finding, hiring, and managing contract workers - enabling companies to deploy workers quickly and efficiently, aggregate staffing suppliers, and optimize business processes.
Imagicast, Inc. specializes in providing strategic merchandising solutions tailored for the retail sector. The company offers a one-to-one merchandising platform that integrates marketing, e-commerce, and business intelligence features. This platform enables retailers and brand manufacturers to create engaging in-store product demonstrations and personalized promotions. Additionally, it helps clients gather insights into customer shopping and purchasing behaviors, ultimately enhancing the conversion of shoppers into buyers. Through its innovative approach, Imagicast aims to improve the effectiveness of retail strategies and foster stronger connections between brands and consumers.
AllAdvantage
Venture Round in 2000
As of January 2001, AllAdvantage Inc. went out of business. AllAdvantage.com, Inc. operates as an Internet advertising company. It pays its users/members a portion of the advertising revenue generated by their online viewing habits. The company also allows members to receive membership benefits that include sponsor discounts and rebates for surfing the Web. In addition, it provides incentives for advertisers to build one-on-one relationships with its members. The company was founded in 1999 and is based in Hayward, California with additional offices in Atlanta, Boston, Chicago, Dallas, Detroit, Hayward, London, Los Angeles, New York, Paris, Seattle, Sydney, and Washington DC.
HeartStent
Venture Round in 1999
HeartStent is a cardiovascular device firm. It is a direct revascularization device intended for coronary artery disease patients currently treated with coronary artery bypass grafts.
Spinal Dynamics
Series A in 1997
Spinal Dynamics develops neuro-surgical devices for the replacement of spinal disks. The company's Bryan Cervical Disc System is an implanted prosthesis designed to replace and mimic the flexibility and shock-absorbing characteristics of natural intervertebral discs. It features a shock-absorbing elastomer that is intended to cushion the vertebrae and allow movement of the head and neck and is designed to replace the disc that is removed from the patient in cervical spine surgery.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.